Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders
Open accessThe DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
While it is generally understood that Alzheimer's disease (AD) and related dementias (ADRD) is one of the costliest diseases to society, there is widespread concern that researchers and policymakers are not comprehensively capturing and describing the full scope and magnitude of the socioeconomic burden of ADRD. This review aimed to 1) catalogue the different types of AD-related socioeconomic costs described in the literature; 2) assess the challenges and gaps of existing approaches to measuring these costs; and 3) analyze and discuss the implications for stakeholders including policymakers, healthcare systems, associations, advocacy groups, clinicians, and researchers looking to improve the ability to generate reliable data that can guide evidence-based decision making. A centrally emergent theme from this review is that it is challenging to gauge the true value of policies, programs, or interventions in the ADRD arena given the long-term, progressive nature of the disease, its insidious socioeconomic impact beyond the patient and the formal healthcare system, and the complexities and current deficiencies (in measures and real-world data) in accurately calculating the full costs to society. There is therefore an urgent need for all stakeholders to establish a common understanding of the challenges in evaluating the full cost of ADRD and define approaches that allow us to measure these costs more accurately, with a view to prioritizing evidence-based solutions to mitigate this looming public health crisis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Global economic costs of ADRD are projected to double from $1 trillion to $2 trillion (USD) in the next decade alone (e.g., from 2018 to 2030) [114,115].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationDementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072 · cited 1×
“Moreover, despite improvements in the quality of care for patients and the identification of several potentially modifiable risk factors [118], the causal mechanisms of ADRD are complex, multifactorial and not fully elucidated, and no disease-modifying intervention is available to delay, halt, or reverse the underlyin…”
BackgroundSelf-citation2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K., & Brayne, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70136-x · Cited by 2,466
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · cited 1×
“dency among older adults worldwide [1], having a significant impact not only on individuals but also on their families, communities, and societies.”
Background(2015) · HAL · Cited by 2,238
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citation2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676 · cited 5×
“, English Longitudinal Study on Aging, Swedish National Study on Aging) and may supply some of these data, these studies have generally been focused on patients with a dementia diagnosis and rely on a limited range of assessments [4, 28].”
BackgroundInfluentialSelf-citation2017 Alzheimer's disease facts and figures
(2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,311
Health outcomes in economic evaluation: the QALY and utilities
Whitehead, S. J., & Ali, S. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq033 · Cited by 1,120 · cited 10×
“While numerous studies have assessed QOL in ADRD, relatively fewer have translated their findings into the health utility or health state values that are required for QALY calculations (see Box 4) [96].”
BackgroundInfluentialBeach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b211b · Cited by 1,103
The worldwide costs of dementia 2015 and comparisons with 2010
Wimo, A., Guerchet, M., Ali, G., Wu, Y., Prina, A. M., Winblad, B., Jönsson, L., Liu, Z., & Prince, M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.150 · Cited by 1,066
(2016) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 874
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Impact of multiple pathologies on the threshold for clinically overt dementia
Kapasi, A., DeCarli, C., & Schneider, J. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1717-7 · Cited by 739
The Alzheimer’s Disease Clinical Spectrum
Atri, A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.009 · Cited by 623
Self-citationDementia Caregiver Burden: a Research Update and Critical Analysis
Cheng, S.-T. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0818-2 · Cited by 595
The interface between delirium and dementia in elderly adults
Fong, T. G., Davis, D., Growdon, M. E., Albuquerque, A., & Inouye, S. K. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00101-5 · Cited by 595
Wolff, J. L., Spillman, B. C., Freedman, V. A., & Kasper, J. D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7664 · Cited by 577 · cited 1×
“In other studies, 327 impairments have been assessed by quantifying 328 employment absenteeism and presenteeism [54, 55].”
BackgroundPreclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Vos, S. J., Xiong, C., Visser, P. J., Jasielec, M. S., Hassenstab, J., Grant, E. A., Cairns, N. J., Morris, J. C., Holtzman, D. M., & Fagan, A. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70194-7 · Cited by 564 · cited 1×
“Addi720 tionally, patients with MCI also contend with an 721 increased risk of mortality [106].”
BackgroundWorld Alzheimer Report 2010: The global economic impact of dementia
Wimo, A. B., & Prince, M. J. (2010) · Cited by 559
Prevalence of Mental Health Disorders Among Caregivers of Patients With Alzheimer Disease
Sallim, A. B., Sayampanathan, A. A., Cuttilan, A., & Chun-Man Ho, R. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.09.007 · Cited by 396 · cited 2×
“2%, with increased probability of depression in female and spousal caregivers [110].”
BackgroundThe Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life
Kelley, A. S., McGarry, K., Gorges, R., & Skinner, J. S. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0381 · Cited by 373
The Disproportionate Impact Of Dementia On Family And Unpaid Caregiving To Older Adults
Kasper, J. D., Freedman, V. A., Spillman, B. C., & Wolff, J. L. (2015) · Health Affairs · doi:10.1377/hlthaff.2015.0536 · Cited by 354
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1099 · Cited by 354
Marson, D. C., Sawrie, S. M., Snyder, S., McInturff, B., Stalvey, T., Boothe, A., Aldridge, T., Chatterjee, A., & Harrell, L. E. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.877 · Cited by 337 · cited 1×
“Moreover, patients with MCI and dementia exhibit impairments in financial abilities and decision-making [81, 82], leading to increased vulnerability to financial exploitation and abuse, which is commonly associated with diminished or impaired mental capacities [83].”
BackgroundFarina, N., Page, T. E., Daley, S., Brown, A., Bowling, A., Basset, T., Livingston, G., Knapp, M., Murray, J., & Banerjee, S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.12.010 · Cited by 335 · cited 2×
“The QOL of ADRD caregivers is a complex construct and is influenced by several factors [95].”
BackgroundAddressing Dementia: The OECD Response
OECD (2015) · OECD Health Policy Studies · doi:10.1787/9789264231726-en · Cited by 327
Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies
Boyle, P. A., Yu, L., Leurgans, S. E., Wilson, R. S., Brookmeyer, R., Schneider, J. A., & Bennett, D. A. (2019) · Annals of Neurology · doi:10.1002/ana.25380 · Cited by 318
Current and future treatments in Alzheimer’s disease
Atri, A. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1678581 · Cited by 309
Self-citationKORA Study Group, Hunger, M., Schwarzkopf, L., Heier, M., Peters, A., & Holle, R. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-1 · Cited by 261 · cited 1×
“For example, it has been shown that survey estimates tend to underestimate healthcare utilization in the elderly population [41], and this effect could be hypothesized to be even potentially greater due to impairments in awareness, insight, memory and cognition in individuals with ADRD.”
BackgroundLiu, S., Li, C., Shi, Z., Wang, X., Zhou, Y., Liu, S., Liu, J., Yu, T., & Ji, Y. (2017) · Journal of Clinical Nursing · doi:10.1111/jocn.13601 · Cited by 250
Physiological and functional consequences of caregiving for relatives with dementia
Fonareva, I., & Oken, B. S. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000039 · Cited by 249
Long-term course and effectiveness of combination therapy in Alzheimer disease
Atri, A., Shaughnessy, L. W., Locascio, J. J., & Growdon, J. H. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31816653bc · Cited by 230
Self-citationCombined neuropathological pathways account for age‐related risk of dementia
Power, M. C., Mormino, E., Soldan, A., James, B. D., Yu, L., Armstrong, N. M., Bangen, K. J., Delano‐Wood, L., Lamar, M., Lim, Y. Y., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25246 · Cited by 217
Bowling, A., Rowe, G., Adams, S., Sands, P., Samsi, K., Crane, M., Joly, L., & Manthorpe, J. (2015) · Aging & Mental Health · doi:10.1080/13607863.2014.915923 · Cited by 217 · cited 3×
“Both the QOL-AD and DEMQOL have been shown to be reliable and valid in patients with mild to moderate dementia and have been recommended as instruments of choice to assess QOL in clinical trials [33, 85].”
BackgroundMethodMonetary Costs of Dementia in the United States
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1305541 · Cited by 211 · cited 2×
“While it is generally acknowledged that ADRD is one of the costliest diseases to society [3, 4], the burden is complex and has been difficult to assess accurately due to myriad factors [2, 4, 5].”
BackgroundMethodWorld Alzheimer Report 2013: Journey of Caring: An analysis of long-term care for dementia
Guerchet, M., Prince, M. J., & Prina, M. A. (2013) · Cited by 210
Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States
Deb, A., Thornton, J. D., Sambamoorthi, U., & Innes, K. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1313118 · Cited by 190 · cited 6×
“While studies relying on surveys and question213 naires may capture a broader range of costs, these 214 are based on self-reported measures and might be 215 subject to inaccuracies [14, 26].”
BackgroundMethodInfluentialBrowne, J., Edwards, D. A., Rhodes, K. M., Brimicombe, D. J., & Payne, R. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012546 · Cited by 186 · cited 1×
“ADRD are elderly and typically suffer from comor198 bidities, such as cerebrovascular disease, albeit at a 199 higher rate compared to individuals without ADRD 200 [39, 40].”
BackgroundApplication of Resource Utilization in Dementia (RUD) instrument in a global setting
Wimo, A., Gustavsson, A., Jönsson, L., Winblad, B., Hsu, M., & Gannon, B. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.06.008 · Cited by 179 · cited 1×
“use data, including Resource Utilization in Dementia 163 (RUD), Client Service Receipt Inventory, Resource 164 Use Inventory, cost diary, and informal care survey 165 [33, 34].”
MethodUnmet Needs of Caregivers of Individuals Referred to a Dementia Care Program
Jennings, L. A., Reuben, D. B., Evertson, L. C., Serrano, K. S., Ercoli, L., Grill, J., Chodosh, J., Tan, Z., & Wenger, N. S. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13251 · Cited by 178
Societal and Family Lifetime Cost of Dementia: Implications for Policy
Jutkowitz, E., Kane, R. L., Gaugler, J. E., MacLehose, R. F., Dowd, B., & Kuntz, K. M. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15043 · Cited by 164 · cited 1×
“dollars and the costs associated with family care make 314 up 70% of lifetime dementia care costs [6, 51].”
BackgroundBremer, P., Cabrera, E., Leino‐Kilpi, H., Lethin, C., Saks, K., Sutcliffe, C., Soto, M. E., Zwakhalen, S. M. G., & Wübker, A. (2015) · Health Policy · doi:10.1016/j.healthpol.2015.09.014 · Cited by 163
Wimo, A., Reed, C. C., Dodel, R., Belger, M., Jones, R. W., Happich, M., Argimon, J. M., Bruno, G., Novick, D., Vellas, B., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122392 · Cited by 162 · cited 5×
“direct costs as a specific and unique consequence of 205 caregiving for an ADRD patient [25].”
BackgroundInfluentialGoren, A., Montgomery, W., Kahle-Wrobleski, K., Nakamura, T., & Ueda, K. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0298-y · Cited by 153
de Wilde, A., van der Flier, W. M., Pelkmans, W., Bouwman, F., Verwer, J., Groot, C., van Buchem, M. M., Zwan, M., Ossenkoppele, R., Yaqub, M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1346 · Cited by 152 · cited 2×
“, medications, counseling, additional testing) (in 60–63%) [133]—results that are consistent with the ABIDE study performed in 507 patients seen at two dementia specialty centers in the Netherlands [134].”
ResultA Comparison of Psychosocial Outcomes in Elderly Alzheimer Caregivers and Noncaregivers
Mausbach, B. T., Chattillion, E. A., Roepke, S. K., Patterson, T. L., & Grant, I. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.001 · Cited by 142 · cited 2×
“, Care673 Related QOL, Caregivers’ QOL Index) have been 674 developed to capture various dimensions unique to 675 caregiver QOL [29].”
BackgroundMethodPredictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients
Gustavsson, A., Brinck, P., Bergvall, N., Kolasa, K., Wimo, A., Winblad, B., & Jönsson, L. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.09.001 · Cited by 140 · cited 3×
“The Zarit Burden Interview (ZBI) is one of the most commonly used scales to assess the subjective burden experienced by informal ADRD caregivers [24, 26, 74, 91, 99].”
MethodZhu, C. W., Scarmeas, N., Ornstein, K., Albert, M., Brandt, J., Blacker, D., Sano, M., & Stern, Y. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.018 · Cited by 137
Wübker, A., Zwakhalen, S. M. G., Challis, D., Suhonen, R., Karlsson, S., Zabalegui, A., Soto, M., Saks, K., & Sauerland, D. (2015) · The European Journal of Health Economics · doi:10.1007/s10198-014-0620-6 · Cited by 132
Pußwald, G., Tropper, E., Kryspin‐Exner, I., Moser, D., Klug, S. J., Auff, E., Dal‐Bianco, P., & Lehrner, J. P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150284 · Cited by 132 · cited 1×
“Patients with subjective cognitive decline and MCI show a decline in almost every dimension of HRQOL compared with matched controls [104, 105].”
Gorina, Y., & Kramarow, E. A. (2011) · Health Services Research · doi:10.1111/j.1475-6773.2011.01277.x · Cited by 131
Jennings, L. A., Laffan, A. M., Schlissel, A. C., Colligan, E., Tan, Z., Wenger, N. S., & Reuben, D. B. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5579 · Cited by 128 · cited 1×
“This study found a reduction of admissions to long-term care facilities and an average direct cost savings of US$284 per participant per quarter (equivalent to US$1,136 per year) [135].”
BackgroundLin, P., Zhong, Y., Fillit, H. M., Chen, E., & Neumann, P. J. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14227 · Cited by 127 · cited 9×
“One recently launched industrysponsored observational cohort study, the Insights to Model Alzheimer’s Progression in Real Life (initiated in January 2019) [132], aims to assess the clinical meaningfulness of selected cognitive test scores that may track changes along the spectrum of preclinical AD, prodromal AD/MCI du…”
InfluentialReed, C., Belger, M., Dell'Agnello, G., Wimo, A., Argimon, J. M., Bruno, G., Dodel, R., Haro, J. M., Jones, R. W., & Vellas, B. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000358234 · Cited by 122
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease
Zhu, C. W., Scarmeas, N., Torgan, R., Albert, M., Brandt, J., Blacker, D., Sano, M., & Stern, Y. (2006) · Neurology · doi:10.1212/01.wnl.0000230160.13272.1b · Cited by 113 · cited 1×
“Several longitudinal studies have shown that the direct patient costs of AD increase over time or with disease severity [24, 25, 27, 46] and are higher in nursing home residents, compared to communitydwelling patients [26, 47].”
BackgroundHaro, J. M., Kahle-Wrobleski, K., Bruno, G., Belger, M., Dell'Agnello, G., Dodel, R., Jones, R. W., Reed, C. C., Vellas, B., Wimo, A., et al. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0500-x · Cited by 109 · cited 1×
“Several studies in community-dwelling ADRD patients have shown that caregiver burden, as measured with the ZBI questionnaire and other approaches, generally increases with disease severity, being directly related to patient functional abilities and level of dependence on the caregiver [91, 108, 109].”
Backgroundvon Känel, R., Mills, P. J., Mausbach, B. T., Dimsdale, J. E., Patterson, T. L., Ziegler, M. G., Ancoli-Israel, S., Allison, M., Chattillion, E. A., & Grant, I. (2012) · Gerontology · doi:10.1159/000334219 · Cited by 109 · cited 1×
“, Role Overload Scale, Caregiver Strain Index), have also been commonly used to measure the subjective and objective aspects of caregiver burden [29, 30, 56, 100].”
MethodEconomic valuation of informal care: the contingent valuation method applied to informal caregiving
van denBerg, B., Brouwer, W., Exel, J. V., & Koopmanschap, M. (2005) · Health Economics · doi:10.1002/hec.893 · Cited by 109 · cited 1×
“The contingent valuation 401 approach [8, 20, 26, 67, 68] is rooted in welfare 402”
BackgroundSeeher, K., Low, L., Reppermund, S., & Brodaty, H. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.01.012 · Cited by 100 · cited 1×
“Similarly, caregiver burden also extends before ADRD symptom onset in caregivers of patients with MCI—depression and psychological comorbidity, although not as pronounced as in dementia caregivers, are common complications [107].”
BackgroundEffectiveness of antidementia drugs in delaying Alzheimer's disease progression
Rountree, S. D., Atri, A., Lopez, O. L., & Doody, R. S. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.01.002 · Cited by 97
Self-citationMethodological considerations in cost of illness studies on Alzheimer disease
Costa, N., Derumeaux, H., Rapp, T., Garnault, V., Ferlicoq, L., Gillette, S., Andrieu, S., Vellas, B., Lamure, M., Grand, A., et al. (2012) · Health Economics Review · doi:10.1186/2191-1991-2-18 · Cited by 90
Implications of Comorbidity on Costs for Patients With Alzheimer Disease
Kuo, T.-C., Zhao, Y., Weir, S., Kramer, M. S., & Ash, A. S. (2008) · Medical Care · doi:10.1097/mlr.0b013e318178940b · Cited by 88 · cited 1×
“Moreover, most patients in the dementia stages of ADRD are elderly and typically suffer from comorbidities, such as cerebrovascular disease, albeit at a higher rate compared to individuals without ADRD [39, 40].”
BackgroundBorsje, P., Hems, M. A. P., Lucassen, P. L. B. J., Bor, H., Koopmans, R. T. C. M., & Pot, A. M. (2016) · Family Practice · doi:10.1093/fampra/cmw009 · Cited by 86
Zhu, C. W., Scarmeas, N., Torgan, R., Albert, M., Brandt, J., Blacker, D., Sano, M., & Stern, Y. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00871.x · Cited by 85 · cited 3×
“Despite the variabilities in informal care cost estimates, several crosssectional and longitudinal studies have demonstrated a direct association between costs and disease severity [25, 57, 59, 60, 78].”
BackgroundMethodLaks, J., Goren, A., Dueñas, H., Novick, D., & Kahle-Wrobleski, K. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4309 · Cited by 83 · cited 2×
“ciated with significantly increased risk of depressive 746 symptoms, anxiety, insomnia, hypertension, pain, 747 and diabetes [87].”
BackgroundHealth economic evaluation of treatments for Alzheimer′s disease: impact of new diagnostic criteria
Wimo, A., Ballard, C., Brayne, C., Gauthier, S., Handels, R., Jones, R. W., Jonsson, L., Khachaturian, A. S., & Kramberger, M. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12167 · Cited by 82
Self-citationDeterminants of societal costs in Alzheimer's disease: GERAS study baseline results
Dodel, R., Belger, M., Reed, C., Wimo, A., Jones, R. W., Happich, M., Argimon, J. M., Bruno, G., Vellas, B., & Haro, J. M. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.005 · Cited by 79
Atri, A., Hendrix, S. B., Pejović, V., Hofbauer, R. K., Edwards, J., Molinuevo, J. L., & Graham, S. M. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0109-2 · Cited by 75
Self-citationThree-Year Trajectories of Caregiver Burden in Alzheimer's Disease
Conde-Sala, J. L., Turró-Garriga, O., Calvó-Perxas, L., Vilalta-Franch, J., Lopez-Pousa, S., & Garre-Olmo, J. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140360 · Cited by 75
Michalowsky, B., Fleßa, S., Eichler, T. S., Hertel, J., Dreier, A., Zwingmann, I., Wucherer, D., Rau, H., Thyrian, J. R., & Hoffmann, W. U. (2017) · The European Journal of Health Economics · doi:10.1007/s10198-017-0869-7 · Cited by 72
Dementia severity and the longitudinal costs of informal care in the Cache County population
Rattinger, G. B., Schwartz, S., Mullins, C. D., Corcoran, C., Zuckerman, I. H., Sanders, C., Norton, M. C., Fauth, E. B., Leoutsakos, J. S., Lyketsos, C. G., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.004 · Cited by 71 · cited 4×
“Despite the variabilities in informal care cost estimates, several crosssectional and longitudinal studies have demonstrated a direct association between costs and disease severity [25, 57, 59, 60, 78].”
BackgroundMethodInfluentialSelf-citationHealth State Values for Use in the Economic Evaluation of Treatments for Alzheimerʼs Disease
Shearer, J., Green, C., Ritchie, C. W., & Zajicek, J. (2011) · Drugs & Aging · doi:10.2165/11597380-000000000-00000 · Cited by 71 · cited 9×
“While numerous studies have assessed QOL in ADRD, relatively fewer have translated their findings into the health utility or health state values that are required for QALY calculations (see Box 4) [96].”
BackgroundInfluentialRoepke, S. K., Allison, M., Von Känel, R., Mausbach, B. T., Chattillion, E. A., Harmell, A. L., Patterson, T. L., Dimsdale, J. E., Mills, P. J., Ziegler, M. G., et al. (2012) · Stress · doi:10.3109/10253890.2011.596866 · Cited by 70
Jones, R. W., Romeo, R., Trigg, R., Knapp, M., Sato, A., King, D., Niecko, T., Lacey, L., & DADE Investigator Group (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.03.001 · Cited by 65 · cited 2×
“Several studies in community-dwelling ADRD patients have shown that caregiver burden, as measured with the ZBI questionnaire and other approaches, generally increases with disease severity, being directly related to patient functional abilities and level of dependence on the caregiver [91, 108, 109].”
BackgroundMethodCost of Dementia in the Pre-Enlargement Countries of the European Union
Luengo-Fernandez, R., Leal, J., & Gray, A. M. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-102019 · Cited by 63 · cited 1×
“It has been noted that productivity losses in patients are generally less relevant in the context of ADRD, since most of those affected are older people who would in most cases be retired [50, 75].”
BackgroundYang, F. B., Dawes, P., Leroi, I., & Gannon, B. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4771 · Cited by 63 · cited 4×
“Both the QOL-AD and DEMQOL have been shown to be reliable and valid in patients with mild to moderate dementia and have been recommended as instruments of choice to assess QOL in clinical trials [33, 85].”
BackgroundMethodInfluentialGervès‐Pinquié, C., Chauvin, P., & Bellanger, M. M. (2014) · Health Policy · doi:10.1016/j.healthpol.2014.01.001 · Cited by 63
Alzheimer's Disease Costs: What We Know and What We Should Take into Account
Colucci, L., Bosco, M., Fasanaro, A. M., Gaeta, G. L., Ricci, G., & Amenta, F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131556 · Cited by 62 · cited 2×
“estimate the socioeconomic burden of ADRD [13].”
BackgroundAndrieu, S., Coley, N., Rolland, Y., Cantet, C., Arnaud, C., Guyonnet, S., Nourhashémi, F., Grand, A., Vellas, B. J., & PLASA group (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.09.003 · Cited by 60 · cited 1×
“The Zarit Burden Interview (ZBI) is one of the most commonly used scales to assess the subjective burden experienced by informal ADRD caregivers [24, 26, 74, 91, 99].”
MethodDementia Caregivers’ Use of Services for Themselves
Martindale-Adams, J., Nichols, L. O., Zuber, J., Burns, R., & Graney, M. J. (2016) · The Gerontologist · doi:10.1093/geront/gnv121 · Cited by 59
Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries
Hunter, C. A., Kirson, N. Y., Desai, U., Cummings, A. K. G., Faries, D. E., & Birnbaum, H. G. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.06.1889 · Cited by 58
Clinical and Ethical Aspects of Financial Capacity in Dementia: A Commentary
Marson, D. C. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.033 · Cited by 58 · cited 1×
“vulnerability to financial exploitation and abuse, 540 which is commonly associated with diminished or 541 impaired mental capacities [83].”
BackgroundMichalowsky, B., Thyrian, J. R., Eichler, T., Hertel, J., Wucherer, D., Flessa, S., & Hoffmann, W. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150600 · Cited by 57
Utility-Based Instruments for People with Dementia: A Systematic Review and Meta-Regression Analysis
Li, L., Nguyen, K., Comans, T. A., & Scuffham, P. (2017) · Value in Health · doi:10.1016/j.jval.2017.09.005 · Cited by 57
Gilligan, A. M., Malone, D. C., Warholak, T. L., & Armstrong, E. P. (2013) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317512467679 · Cited by 55 · cited 2×
“, there also appears to be significant gender and racial/ethnic disparities in prevalence, access, and costs related to CID, with costs and care burden being much higher in women and minorities, particularly Blacks/African American [6, 12].”
BackgroundPre-Diagnosis Excess Acute Care Costs in Alzheimer’s Patients among a US Medicaid Population
Geldmacher, D. S., Kirson, N. Y., Birnbaum, H. G., Eapen, S., Kantor, E., Cummings, A. K., & Joish, V. N. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0038-9 · Cited by 53
Possin, K. L., Merrilees, J., Bonasera, S. J., Bernstein, A., Chiong, W., Lee, K., Wilson, L., Hooper, S. M., Dulaney, S., Braley, T., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002260 · Cited by 53 · cited 1×
“Other interventional, care coordination, and real-world studies of care ecosystems are underway [136] and will be needed to provide the evidence-base to support the face validity that timely CID diagnosis and coordinated comprehensive support and care not only improve short- and long-term outcomes but also lead to lon…”
BackgroundAbdollahpour, I., Nedjat, S., Noroozian, M., Salimi, Y., & Majdzadeh, R. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988714524627 · Cited by 52
Jones, R. W., Lebrec, J., Kahle-Wrobleski, K., Dell’Agnello, G., Bruno, G., Vellas, B., Argimon, J. M., Dodel, R., Haro, J. M., Wimo, A., et al. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000461577 · Cited by 51
Wimo, A., Jönsson, L., Fratiglioni, L., Sandman, P. O., Gustavsson, A., Sköldunger, A., & Johansson, L. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0215-9 · Cited by 51 · cited 2×
“Another report using registry data from the Swedish Social Insurance Agency estimated productivity losses in individuals who were prematurely retired or on sick leave due to a dementia diagnosis [69].”
BackgroundTrigg, R., Jones, R. W., Knapp, M. R. J., King, D., Lacey, L. A., & Groups, F. T. D. I. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4150 · Cited by 51
Ku, L.-J. E., Pai, M.-C., & Shih, P.-Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148779 · Cited by 50 · cited 2×
“disease severity [24, 25, 27, 46] and are higher in 265 nursing home residents, compared to community266 dwelling patients [26, 47].”
BackgroundProxy-rated quality of life in Alzheimer's disease: a three-year longitudinal study
Vogel, A., Bhattacharya, S., Waldorff, F. B., & Waldemar, G. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211001128 · Cited by 50
Gustavsson, A., Green, C., Jones, R. W., Förstl, H., Simsek, D., de Vulpillieres, F. D. R., Luthman, S., Adlard, N., Bhattacharyya, S., & Wimo, A. B. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.005 · Cited by 50
Heßmann, P., Seeberg, G., Reese, J. P., Dams, J., Baum, E., Müller, M. J., Dodel, R., & Balzer-Geldsetzer, M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150835 · Cited by 50
König, H.-H., Leicht, H., Brettschneider, C., Bachmann, C., Bickel, H., Fuchs, A., Jessen, F., Köhler, M., Luppa, M., Mösch, E., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.10.003 · Cited by 48
Health, social and economic consequences of dementias: a comparative national cohort study
Frahm‐Falkenberg, S., Ibsen, R., Kjellberg, J., & Jennum, P. (2016) · European Journal of Neurology · doi:10.1111/ene.13043 · Cited by 45 · cited 4×
“inpatient costs, medication, public health Insurance, 492 and indirect costs such as foregone earnings) [22].”
BackgroundMethodInfluentialChange and predictors of quality of life in institutionalized older adults with dementia
de Castro-Monteiro, E., Forjaz, M. J., Ayala, A., Rodríguez‐Blázquez, C., Fernández‐Mayoralas, G., Díaz-Redondo, A., & Martínez‐Martín, P. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0706-8 · Cited by 45
Farré, M., Haro, J. M., Kostov, B., Alvira, C., Risco, E., Miguel, S., Cabrera, E., & Zabalegui, A. (2015) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2015.10.012 · Cited by 43 · cited 3×
“The contingent valuation approach [8, 20, 26, 67, 68] is rooted in welfare economics and presents subjects with a hypothetical market situation to obtain their monetary valuation of a hypothetical change.”
BackgroundMethodStewart, N. J., Morgan, D., Karunanayake, C. P., Wickenhauser, J. P., Cammer, A. L., Minish, D. P., O’Connell, M. E., & Hayduk, L. A. (2014) · Journal of Applied Gerontology · doi:10.1177/0733464813517547 · Cited by 42 · cited 1×
“For example, the majority, approximately two-thirds, of informal caregivers are women [6, 62–64], and a disproportionate burden of caregiving has been demonstrated to fall on wives and daughters compared to husbands and sons [65, 66].”
BackgroundGender Differences: A Lifetime Analysis of the Economic Burden of Alzheimer's Disease
Yang, Z., & Levey, A. (2015) · Women's Health Issues · doi:10.1016/j.whi.2015.06.001 · Cited by 40
Gustavsson, A., Jönsson, L., McShane, R. H., Boada, M., Wimo, A. B., & Zbrozek, A. S. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2385 · Cited by 40 · cited 2×
“It has been suggested that such approaches can overcome the challenges associated with the valuation of leisure time described above and bring the added benefit of incorporating caregivers’ preferences [68].”
BackgroundPußwald, G., Moser, D., Pflüger, M., Gleiß, A., Auff, E., Stögmann, E., Dal‐Bianco, P., & Lehrner, J. P. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216001289 · Cited by 40 · cited 1×
“Patients with subjective cognitive decline and MCI show a decline in almost every dimension of HRQOL compared with matched controls [104, 105].”
Caregiver Burden in Alzheimer's Disease Patients in Spain
Peña-Longobardo, L. M., & Oliva, J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141374 · Cited by 40
Getsios, D., Migliaccio–Walle, K., & Caro, J. J. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725120-00003 · Cited by 40
Rattinger, G. B., Fauth, E. B., Behrens, S., Sanders, C., Schwartz, S., Norton, M. C., Corcoran, C., Mullins, C. D., Lyketsos, C. G., & Tschanz, J. T. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.008 · Cited by 39 · cited 1×
“For instance, a longitudinal 518 study using the population-based community cohort 519 with dementia from the Cache County Study found 520 that informal costs increased by approximately 18% 521 per year, and that compared to very mild dementia, 522 informal costs increased over 2-fold for mild, 5-fold 523 for moderate…”
BackgroundSelf-citationSuehs, B. T., Shah, S. N., Davis, C. D., Alvir, J., Faison, W. E., Patel, N. C., van Amerongen, D., & Bobula, J. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12694 · Cited by 39
Zhang, Y., Kivipelto, M., Solomon, A., & Wimo, A. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110065 · Cited by 34
Lenox‐Smith, A., Reed, C. C., Lebrec, J., Belger, M. A., & Jones, R. W. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0371-6 · Cited by 34 · cited 3×
“Several longitudinal studies have shown that the direct patient costs of AD increase over time or with disease severity [24, 25, 27, 46] and are higher in nursing home residents, compared to communitydwelling patients [26, 47].”
BackgroundMethodFactors associated with quality of life among family members of patients with dementia in Cyprus
Papastavrou, E., Andreou, P., Middleton, N., Papacostas, S., & Georgiou, I. K. (2013) · International Psychogeriatrics · doi:10.1017/s104161021300224x · Cited by 33
Taipale, H. T., Purhonen, M., Tolppanen, A., Tanskanen, A. J., Tiihonen, J., & Hartikainen, S. A. (2015) · Scandinavian Journal of Public Health · doi:10.1177/1403494815614705 · Cited by 30
Chiatti, C., Furneri, G., Rimland, J. M., Demma, F., Bonfranceschi, F., Cassetta, L., Masera, F., Cherubini, A., Corsonello, A., & Lattanzio, F. (2015) · International Psychogeriatrics · doi:10.1017/s104161021500040x · Cited by 30 · cited 4×
“Questionnaires such as the RUD and the RUD-Lite form the foundation of two common approaches to quantifying the value of informal care costs; namely, the replacement cost approach [48, 56] and the opportunity cost approach (also referred to as the forgone wages or human capital approach) [21, 57–59].”
MethodInfluentialLongitudinal costs of caring for people with Alzheimer's disease
Gillespie, P., O’Shea, E., Cullinan, J., Buchanan, J., Bobula, J. D., Lacey, L. A., Gallagher, D., Mhaoláin, Á. N., & LAWLOR, B. A. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214002063 · Cited by 29
Lin, P.-J., Yang, Z., Fillit, H. M., Cohen, J. T., & Neumann, P. J. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1276 · Cited by 28
Darbà, J., & Kaskens, L. (2015) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s81045 · Cited by 27
Financial capacity in dementia: a systematic review
Sudo, F. K., & Laks, J. (2016) · Aging & Mental Health · doi:10.1080/13607863.2016.1226761 · Cited by 27 · cited 1×
“Moreover, patients with MCI and dementia exhibit impairments in financial abilities and decision-making [81, 82], leading to increased vulnerability to financial exploitation and abuse, which is commonly associated with diminished or impaired mental capacities [83].”
BackgroundCosts of dementia in the Czech Republic
Holmerová, I., Hort, J., Rusina, R., Wimo, A. B., & Šteffl, M. (2016) · The European Journal of Health Economics · doi:10.1007/s10198-016-0842-x · Cited by 27
Molinuevo, J. L., Minguillón, C., Rami, L., & Gispert, J. D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170698 · Cited by 25
Self-citationBrüggenjürgen, B., Andersohn, F., Ezzat, N., Lacey, L. A., & Willich, S. N. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1014090 · Cited by 23 · cited 3×
“Additionally, regions vary in the way that resources (and associated costs) are classified as belonging to the healthcare and/or social care systems, further complicating the task of delineating which stakeholder will shoulder the cost [22, 26, 38].”
BackgroundInfluentialDepression in the Family of Patients With Dementia in Korea
Jang, S.-I., Bae, H.-C., Shin, J., Jang, S.-Y., Hong, S., Han, K.-T., & Park, E.-C. (2016) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317515628048 · Cited by 19
Moschetti, K., Barragan, N. C., Basurto‐Dávila, R., Cummings, P. L., Sorvillo, F. J., & Kuo, T. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000017 · Cited by 17 · cited 2×
“For example, one study estimated productivity losses due to premature mortality from AD based on US death certificates from 1999 to 2010 [76].”
BackgroundSpecial topic section on health economics and public policy of Alzheimer's disease
Jönsson, L., Lin, P., & Khachaturian, A. S. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.02.004 · Cited by 17 · cited 4×
“While it is generally acknowledged that ADRD is one of the costliest diseases to society [3, 4], the burden is complex and has been difficult to assess accurately due to myriad factors [2, 4, 5].”
BackgroundInfluentialCall for a Uniform Strategy of Collecting Alzheimer’s Disease Costs: A Review and Meta-Analysis
Marešová, P., Dolejš, J., & Kuča, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171028 · Cited by 15
Yu, H., Gao, C., Zhang, Y., He, R., Zhou, L., & Liang, R. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4551 · Cited by 13
Lacey, L. A., Bobula, J. D., Niecko, T., & Leibman, C. W. (2016) · Neurology and Therapy · doi:10.1007/s40120-016-0056-2 · Cited by 12 · cited 3×
“Despite the variabilities in informal care cost estimates, several crosssectional and longitudinal studies have demonstrated a direct association between costs and disease severity [25, 57, 59, 60, 78].”
BackgroundMethodDavidson, M. H., & Beeri, M. S. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.2/mdavidson · Cited by 11 · cited 3×
“The contingent valuation approach [8, 20, 26, 67, 68] is rooted in welfare economics and presents subjects with a hypothetical market situation to obtain their monetary valuation of a hypothetical change.”
BackgroundGraf, A., Risson, V., Gustavsson, A., Bezlyak, V., Caputo, A., Tariot, P., Langbaum, J., Lopez-Lopez, C., & Viglietta, V. (2018) · The journal of prevention of Alzheimer's disease · doi:10.14283/jpad.2018.49 · Cited by 9 · cited 1×
“ated in January 2019) [132], aims to assess the clinical 884”
Background[DT‐01–01]: IMPACT OF AMYLOID PET ON PATIENT MANAGEMENT: EARLY RESULTS FROM THE IDEAS STUDY
Rabinovici, G. D., Gatsonis, C. G., Apgar, C., Gareen, I. F., Hanna, L., Hendrix, J. A., Hillner, B. E., Olson, C. L., Romanoff, J., Siegel, B. A., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.08.003 · Cited by 9 · cited 1×
“, medications, counseling, additional testing) (in 60–63%) [133]—results that are consistent with the ABIDE study performed in 507 patients seen at two dementia specialty centers in the Netherlands [134].”
ResultAtri, A., Knopman, D. S., Norman, M., Karlawish, J., Sano, M., Onyike, C. U., Lin, P., Clevenger, C., Scanland, S., Hendrix, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.110 · Cited by 6 · cited 1×
“efits related to establishing and implementing best clinical practices [142] to improve timely diagnosis, disclosure, treatments, and care interventions in the CID spectrum due to ADRD.”
BackgroundSelf-citation
Research works printed but not linked: 1
- World Health Organization. First WHO Ministerial Conference on Global Action Against Dementia.
Cited by
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Meng, Y., Hynynen, K., & Lipsman, N. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00418-z · Cited by 505
Economic burden of Alzheimer disease and managed care considerations
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc.2020.88482 · Cited by 398
Nandi, A., Counts, N., Chen, S., Seligman, B., Tortorice, D., Vigo, D., & Bloom, D. E. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101580 · Cited by 402
Liss, J. L., Seleri Assunção, S., Cummings, J., Atri, A., Geldmacher, D. S., Candela, S. F., Devanand, D. P., Fillit, H. M., Susman, J., Mintzer, J., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13244 · Cited by 312
Self-citationNeuroprotective Herbs for the Management of Alzheimer’s Disease
Gregory, J., Vengalasetti, Y. V., Bredesen, D. E., & Rao, R. V. (2021) · Biomolecules · doi:10.3390/biom11040543 · Cited by 236
“While many new approaches to symptomatic treatment and disease-modifying therapy are currently under development for AD, the final outcome of their development to the market is uncertain [1,2,182,183].”
BackgroundInfluential
Metadata
- Authors
- El-Hayek, Y. H., Wiley, R. E., Khoury, C. P., Daya, R. P., Ballard, C., Evans, A. R., Karran, M., Molinuevo, J. L., Norton, M., & Atri, A.
- Affiliations
- Shift Health, Toronto, ON, Canada
- McMaster University (CA)
- University of Exeter (GB)
- Alzheimer’s Research UK (GB)
- Barcelonaβeta Brain Research Center, Barcelona, Spain
- Brigham and Women's Hospital (US)
- Corresponding author
- Atri, Alireza
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2019-07-23
- Volume
- 70
- Issue
- 2
- Pages
- 323-341
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC6700654
- OpenAlex
- W2954682095
- Cited by
- 216
- References
- 132
- Citations by year
- 2026: 10 · 2025: 33 · 2024: 28 · 2023: 34 · 2022: 47 · 2021: 40 · 2020: 23 · 2019: 1
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, cc-by-nc)
- Funders
- F. Hoffmann-La Roche
- National Institute on Aging (P30AG019610)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, related dementias
- MeSH terms
- Stakeholder Participation, Alzheimer Disease, Dementia, Humans, Socioeconomic Factors, Global Health, Health Care Costs, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.